Strides receives USFDA approval for Fluoxetine Tabs 60 mg; Expanding the Product s Availability Across Strengths.
Press Release Sep 16 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Earlier from Strides Pharma Science
- Press Release Sep 11 2024
- Press Release Sep 06 2024
- Intimation of Board Meeting scheduled on July 29, 2024
- Press Release May 22 2024
- Intimation of Board Meeting scheduled on May 22, 2024
Later from Strides Pharma Science
- Strides Pharma Science Ltd Press Release Oct 16 2024
- Intimation of Board Meeting scheduled on October 24, 2024
- Press Release Oct 24 2024
- Press Release Jan 20 2025
- Intimation of Board Meeting scheduled on January 30, 2025
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science